Aspirin to be investigated as potential treatment for COVID-19 By: MarketWatch November 06, 2020 at 09:14 AM EST At least 2,000 patients in the RECOVERY trial are expected to randomly get 150 mg of aspirin daily Read More >> Related Stocks: Regeneron Pharmaceuticals